DNA Damage and Its Links to Neurodegeneration by Madabhushi, Ram et al.
DNA damage and its links to neurodegeneration
Ram Madabhushi1,2, Ling Pan1,2, and Li-Huei Tsai1,2,*
1Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, 
MA 02139 USA
2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, 
MA 02139 USA
Abstract
The integrity of our genetic material is under constant attack from numerous endogenous and 
exogenous agents. The consequences of a defective DNA damage response are well studied in 
proliferating cells, especially with regards to the development of cancer, yet its precise roles in the 
nervous system are relatively poorly understood. Here we attempt to provide a comprehensive 
overview of the consequences of genomic instability in the nervous system. We highlight the 
neuropathology of congenital syndromes that result from mutations in DNA repair factors and 
underscore the importance of the DNA damage response in neural development. In addition, we 
describe the findings of recent studies, which reveal that a robust DNA damage response is also 
intimately connected to aging and the manifestation of age-related neurodegenerative disorders 
such as Alzheimer’s disease and amyotrophic lateral sclerosis.
Introduction
Upon analyzing the data collected in the 2000 census, health officials arrived at the 
remarkable prediction that by the year 2050, approximately 800,000 Americans would live 
to see their hundredth birthday (Park, 2010). Even with the benefits of modern medical 
technology, it is miraculous that our bodies can sustain themselves for a century. Each cell in 
the human body incurs thousands of lesions per day to its constituent lipids, proteins, and 
nucleic acids from sources that range from the products of cellular metabolism to the myriad 
environmental chemicals, pollutants, and high-frequency electromagnetic radiation. While 
some cells only need endure this onslaught for a short time and are replaced continuously 
(for instance, epithelial cells lining the intestine have an average lifespan of 5 days), others 
such as neurons are retained for life and therefore require the means to cope with a lifetime 
of damage.
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All biological macromolecules are susceptible to corruption; however, damage to a cell’s 
genomic DNA is particularly harmful because DNA is the blueprint for protein production 
and unlike other molecules, it cannot simply be replaced by re-synthesis. DNA damage 
induces mutations and chromosomal aberrations that can lead either to cellular dysfunction 
or to the formation of cancer, and encounters with certain DNA lesions can derail 
transcription and replication, and thereby trigger cell death, senescence, and aging 
(Hoeijmakers, 2009). Accordingly, cells devote enormous resources for the purpose of 
genome maintenance and have evolved elaborate systems to repair damaged DNA. In this 
review, we focus on the consequences of DNA damage in the nervous system, taking into 
account the insights obtained from neurological disorders that manifest from a defective 
DNA damage response. A majority of these disorders are congenital; however several recent 
studies suggest that defective DNA repair also underlies brain aging and age-associated 
neurodegeneration and we also discuss the implications of these studies.
The cellular DNA damage response
On any given day, a listing of endogenous DNA damage experienced by a typical 
mammalian cell would read something as follows – 200 cytosine deaminations, 3000 
guanine methylations, 10000 spontaneous depurinations, 10000–100000 oxidative lesions, 
10000 single strand breaks, and 10–50 double strand breaks (Ames et al., 1993; Haber, 
1999; Lindahl, 1993; Nakamura et al., 1998; Vilenchik and Knudson, 2003). To avert the 
potentially catastrophic consequences of these lesions, cells activate a highly evolved DNA 
damage response (DDR) that not only detects and repairs damaged DNA, but also 
coordinates repair with other cellular processes, such as chromatin remodeling, transcription, 
cell cycle progression (in dividing cells), and apoptosis (Jackson and Bartek, 2009). A truly 
remarkable feature of the DDR is that each class of lesion elicits its own distinct damage 
detection and repair mechanism. For instance, thymidine dimers generated upon exposure to 
UV light are repaired using nucleotide excision repair, whereas a separate base excision 
repair pathway is utilized to repair oxidative lesions such as 8-oxo-dG. However, the same 
lesion can also be repaired using diverse mechanisms depending upon cell cycle stage, 
developmental status, and tissue type. As an example, whereas a majority of DNA double 
strand breaks are repaired through nonhomologous end joining (NHEJ), a specialized 
pathway called homologous recombination (HR) is employed to repair double strand breaks 
that are produced in the S and G2 phases of the cell cycle.
Although relatively stable compared to other macromolecules, DNA bases frequently 
undergo modification by alkylation, oxidation, and deamination. In fact, reactive oxygen 
species (ROS) alone generate more than 100 different oxidative base modifications and these 
alterations have the potential to be highly mutagenic (Iyama and Wilson, 2013). The brain is 
thought to metabolize as much as a fifth of consumed oxygen. Accordingly, a number of 
studies have shown that ROS are a major source of DNA damage in the brain. The base 
excision repair (BER) machinery has evolved to specifically solve these problems. The main 
strategy in BER consists of converting the large array of modified base substrates into a few 
intermediates that can then be processed by the core BER components of APE1, polβ, and 
XRCC1/LIG3. This step is mediated primarily by enzymes called DNA glycosylases 
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(humans contain at least 15) that specialize in detecting distinct modified bases and excising 
them through cleavage of the N-glycosidic bond (Lindahl, 1974).
Like BER, the nucleotide excision repair (NER) pathway also resolves modified bases and 
follows the general program of damage detection, excision, gap-filling DNA synthesis and 
ligation, the distinguishing feature of NER being that it senses structural distortions in the 
double helix rather than specific base modifications. This confers NER with the versatility to 
operate ona range of highly diverse substrates, such as the cyclobutane pyrimidine dimers 
(CPDs) and 6,4-photoproducts (6-4PPs) generated by UV radiation, DNA adducts that arise 
from intercalation of chemicals such as benzopyrene (a component of cigarette smoke), 
psoralen, and cisplatin, and cyclopurines formed by attacks of the hydroxyl radical on 2′-
deoxyadenosine and 2′-deoxyguanosine. These “bulky” lesions typically obstruct the 
progression of transcription and replication machineries, and can thereby induce cellular 
dysfunction and apoptosis (de Laat et al., 1999). More than 30 different proteins work 
collaboratively in NER, which is broadly categorized into two classes – global genome NER 
(GG-NER), which resolves lesions throughout the genome, and transcription-coupled NER 
(TC-NER), which specializes in the removal of damage on the transcribed strand of DNA 
within active genes.
In addition to generating numerous base modifications, ROS-mediated attack on the DNA 
backbone and sugar fragmentation can also lead to the formation of DNA single strand 
breaks (SSBs). More indirectly, SSBs may also arise as intermediates of the BER pathway or 
as byproducts of abortive DNA topoisomerase I (TOP1) reactions (Caldecott, 2008).
The primary challenge in the repair of SSBs is to generate DNA ends that are compatible for 
ligation, which is to say, a 3′ hydroxyl and a 5′phosphate, and depending on the lesion this 
step may require diverse end-processing activities (Figure 1). Like in BER, any gap-filling 
synthesis is mediated by polβ and nicks are sealed by either XRCC1/LIG3 or FEN1/LIG1 
(Figure 1). Under certain conditions, such as the generation of SSBs in close proximity to 
each other or encounters between an existing SSB and either the transcription or replication 
machineries (leading to their collapse) can cause SSBs breaks to be converted to DNA 
double strand breaks (DSBs). In addition to these, ionizing radiation and chemotherapeutic 
drugs are prominent environmental DSB-inducing agents. When compared to other lesions, 
DNA DSBs are rare events; however, DSBs are also extremely deleterious because they can 
cause large chromosome rearrangements that can either lead to cell death, or promote 
tumorigenesis (Jackson, 2002). Furthermore, even a few DSBs are sufficient to trigger 
apoptosis in proliferating cells (although whether neurons have a higher tolerance for DNA 
DSB accumulation has not been thoroughly investigated) (Rich et al., 2000). DSBs are 
repaired using one of two main pathways – nonhomologous end joining (NHEJ), which 
involves direct ligation of the broken DNA ends and is error prone, or homologous 
recombination (HR), which is selectively utilized in the S and G2 phases of the cell cycle 
and employs homologous sequences in the sister chromatid as a template to ensure error-free 
repair (Lombard et al., 2005). Because neurons are postmitotic cells, NHEJ is the primary 
pathway of DSB repair in neurons, although HR is likely important for DNA repairin neural 
progenitors and non-neuronal cells in the brain. In NHEJ, DSBs are recognized by the 
KU70/KU80 heterodimer, which binds the DNA ends and then recruits and activates the 
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catalytic subunit of the DNA-dependent protein kinase, DNA-PKcs. Activation of DNA-
PKcs allows end-processing activities such as the ARTEMIS, APLF and PNKP to access the 
broken DNA ends and prepare them for ligation. The XRCC4/LIG4 complex is then 
recruited, which acts in concert with proteins such as XLF to promote religation (Figure 2). 
However, it is important to note that while the importance of NHEJ in postmitotic neurons in 
vitro and in newly differentiated neurons in vivo has been established in various studies, its 
precise roles in neurons in the mature brain has not been characterized extensively. Studies 
that involve conditional ablation of NHEJ factors in the mature nervous system will provide 
key insights into these issues. Together, the collaborative efforts of these diverse DNA repair 
pathways ensures that cells remain functional despite the numerous lesions they accumulate 
daily.
Chromatin modifications in the DNA damage response
Both DNA damage and the concomitant response occur in the context of chromatin. 
Traditionally, this has been interpreted to mean that chromatin organization imposes a 
barrier that must be overcome to allow DNA repair activities to access damaged sites, 
following which the original chromatin configuration is restored. However, in contrast to this 
somewhat passive view of chromatin organization, more recent models emphasize that 
chromatin changes in the DDR play active roles in stabilization of the repair machinery, in 
the propagation of the DDR, and in the regulation of transcription in the vicinity of damaged 
sites (Smerdon, 1991; Soria et al., 2012). Furthermore, the discovery of roles for histone 
deacetylases and other chromatin compacting activities at the earliest stages following the 
induction of DNA damage suggest that chromatin changes at damaged sites are more 
dynamic than previously conceived.
Generally, four main activities are thought to be important for chromatin changes in 
response to DNA damage – post-translational modifications of histone tails and chromatin 
modifying enzymes, ATP-dependent chromatin remodelers, histone variants, and histone 
chaperones. Although categorized in this manner, it is important to note that there is 
extensive crosstalk between these mechanisms during damage detection, repair and the 
restoration of chromatin organization following repair. ATP-dependent chromatin 
remodelers in DNA repair are summarized in Table 1 and the reader is referred to several 
excellent reviews on the topics of histone variants and chaperones in the DDR (Avvakumov 
et al., 2011; Soria et al., 2012). Here we limit our discussion to a broad overview of post-
translational chromatin modifications in the DDR (Figure 3).
The modification of histone tails serves as an important way through which DNA 
accessibility, chromatin dynamics, and the binding of non-histone proteins are regulated in 
the DDR. The N-terminal extensions of histones are the sites of most modifications, such as 
poly-ADP-ribosylation, phosphorylation, acetylation, methylation, ubiquitination, and 
sumoylation. One of the earliest detectable modifications following the induction of DNA 
strand breaks is poly-ADP-ribosylation (PARylation) that is mediated by poly-(ADP-ribose) 
polymerases (PARPs). PARP1 is a ubiquitous nuclear protein containing an N-terminal DNA 
binding domain composed primarily of two zinc finger motifs, a central BRCT motif 
containing auto-modification domain that mediates interaction with other DNA repair 
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proteins, and a C-terminal catalytic domain that binds NAD+ and transfers ADP-ribose from 
NAD+ to acceptor sites on proteins (Krishnakumar and Kraus, 2010). PARP1 senses DNA 
strand breaks and upon activation, catalyzes the assembly of poly-(ADP-ribose) (PAR) 
chains onto histones and other protein substrates including itself. Several lysine residues on 
histones, such as K13 of H2A, K30 of H2B, K27 and K37 of H3, and K16 of H4 have been 
identified as ADP-ribose acceptor sites on histones (Messner et al., 2010), although 
glutamate and aspartate residues have also been identified as acceptor sites on other targets. 
The PAR chains cause the nucleation of various chromatin modifiers. For instance, the 
recruitment of PAR-interacting factors such as ALC1 and the ATP-dependent chromatin 
remodeler, SNF2H, has also been shown to promote nucleosome sliding and greater 
accessibility to DNA ends, whereas the recruitment of NuRD, polycomb, and macroH2A (an 
H2A variant) is thought to mediate chromatin looping and compaction (Ahel et al., 2009; 
Chou et al., 2010; Lukas et al., 2011). While chromatin modulation through PARylation 
mediates several important functions in the DDR, it is becoming increasingly clear that the 
regulation of PAR levels is also a critical determinant of survival. PAR levels are tightly 
regulated through the activities of PAR glycohyrolase (PARG), which cleaves PAR chains, 
and terminal ADP-ribose glycohydrolase (TARG), which removes the proximal ADP-ribose 
directly linked to the target protein. Defects in PARG and TARG1 have been shown to cause 
neurodegeneration (Tallis et al., 2014). In addition, prolonged PARP activity can cause the 
depletion of NAD+ and trigger an energy crisis within cells, leading to a form of apoptosis 
referred to as parthenos.
An extremely well-studied histone modification in the DDR is the phosphorylation of the 
histone H2A variant, H2AX, at Ser139 (γH2AX) (Burma et al., 2001). Three PI-3 kinases, 
ATM, ATR and DNA-PK, are known to phosphorylate H2AX. γH2AX appears immediately 
following formation of DNA DSBs, and can spread to upto a megabase in the vicinity of the 
DSB. The phosphorylation of H2AX at Ser139 is accompanied simultaneously by 
dephosphorylation at Tyr142 and these events allow recognition of γH2AX by a protein 
called MDC1 (mediator of DNA damage checkpoint protein 1). The recruitment of MDC1 
coordinates virtually every aspect of the DSB signaling response (Lukas et al., 2011). MDC1 
allows for propagation of γH2AX adjacent to DSB sites, interacts with proteins such as 
ATM, TOPBP1 and CHK2 and activate checkpoint responses in proliferating cells, and also 
coordinates other post-translational modifications such as histone ubiquitination and 
acetylation. For instance, ATM-mediated phosphorylation of MDC1 stimulates the 
recruitment of the H2A ubiquitin ligases RNF8 and RNF168 (Lukas et al., 2011). 
Ubiquitination of H2A by RNF8 and RNF168 facilitates the binding sites of downstream 
factors, such as BRCA1(breast cancer 1), 53BP1 (p53-binding protein 1) and the E3 
ubiquitin-protein ligase, RAD18, all of which are essential for DSB repair.
In addition to these modifications, the significance of histone acetylation in the DDR has 
become a major focus of recent studies. Increased histone acetylation following UV-damage 
is one of the first identified chromatin modifications associated with DNA damage. In 
particular, acetylation of histone H3 Lys56 (H3K56) is believed to promote nucleosome 
assembly in DNA repair and DNA synthesis (Das et al., 2009). Similarly, acetylation of 
H4K16 is known to unfold compact chromatin fibers (Shogren-Knaak and Peterson, 2006). 
Consistently, histone acetyltransferases (HATs) that mediate these modifications, such as 
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MOF, a specific H4K16 HAT, as well as Tip60 and CBP/P300, less specific HATs that 
acetylate both histone and non-histone proteins, play pivotal roles in DNA repair (Das et al., 
2009; Ikura et al., 2000; Li et al., 2010).
Meanwhile, based on the notion that DNA repair requires chromatin relaxation, histone 
deacetylation and histone deacetylases (HDACs) were long believed to only participate at 
the later stages of DNA repair, primarily to restore chromatin structure. However, recent 
studies in several systems, including postmitotic neurons, have unveiled the roles of HDACs 
and chromatin compaction in the early phase of DNA repair (Dobbin et al., 2013; Miller et 
al., 2010; O’Hagan et al., 2008). Intriguingly, although acetylation of H3K56 and H4K16 are 
important for DNA repair, deacetylation of these residues has been observed to occur 
immediately after the formation of DSBs, whereas the re-acetylation is usually observed 
hours after DNA damage (Miller et al., 2010). In addition, H4K16 deacetylation facilitates 
53BP1 foci formation and NHEJ repair (Hsiao and Mizzen, 2013). Given the positive role of 
acH4K16 in transcriptional activation (Taylor et al., 2013), it is also possible that the 
transient removal of this modification serves to inhibit local transcription. Incidentally, ATM 
activity was also shown to cause transcriptional silencing and prevent RNA polymerase II 
elongation-dependent chromatin decondensation in cis of DNA DSBs (Shanbhag et al., 
2010). Histone deacetylation and chromatin compaction may also prevent the excessive 
processing of DNA ends and the uncontrolled expanding of repair factors into adjacent 
chromatin. SIRT6, HDAC1 and HDAC2 have all been implicated as H3K56 deacetylases, 
whereas HDAC1 and HDAC2 have been reported to deacetylate H4K16 (Miller et al., 2010; 
Toiber et al., 2013). SIRT6 increases the binding of SNF2H to nucleosomes and deacetylates 
H3K56 simultaneously. Decreased SNF2H-chromatin association, increased H3K56 
acetylation and accumulated DNA damage are detected in the brains of Sirt6 KO mice, 
suggesting a physiological role of SIRT6 in maintaining genomic integrity in the central 
nervous system (Schwer et al., 2010; Toiber et al., 2013). In addition to its deacetylase 
activity, SIRT6 also has mono-ADP ribosyltransferase activity and is shown to promote BER 
repair through activating PARP1 (Mao et al., 2011; Mostoslavsky et al., 2006). Furthermore, 
the deacetylation of histones at DSBs is also associated with transient H3K9 methylation 
(Price and D’Andrea, 2013). Together, these results suggest that a compact chromatin state 
might prevail immediately after the formation of DNA damage. Such chromatin compaction 
could be important for the synapsis of DNA ends and to inhibit transcription in regions 
flanking damaged DNA. This transient compaction is then followed by an “open” chromatin 
state that allows repair proteins to be loaded to DNA damaged sites (Figure 4).
DNA repair during neural development
Human neural development commences in the third week of gestation with the specification 
of neural progenitors during gastrulation. From the end of gastrulation until about embryonic 
day 42 (E42), neural progenitors undergo symmetric divisions that enormously expand the 
size of the progenitor pool. Thereafter, neural progenitors switch to an “asymmetric” mode 
of division wherein each round yields one progenitor cell and one “post-mitotic” neuron. 
Newborn neurons then migrate from the proliferative zones to their final destinations in 
various regions of the CNS, and upon reaching their targets, undergo further differentiation 
and ultimately become integrated into functional networks.
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DNA repair is extremely important in the early developmental stages because unrepaired 
lesions and mutations at this stage can have a huge effect on the formation of a functional 
nervous system (McKinnon, 2013). In fact, mouse models that involve germline deletions of 
various DNA repair factors clearly illustrate this point. For instance, as mentioned above, 
polβ is the polymerase that primarily mediates repair associated DNA synthesis in BER and 
SSBR. Targeted deletion of polβ causes neonatal lethality with widespread apoptosis of 
newly formed neurons in the developing CNS and PNS (Sugo et al., 2000). Similarly, 
deletion of either Xrcc2 or Lig4, which are essential for DSB repair through HR and NHEJ, 
respectively, results in embryonic lethality that is also associated with extensive apoptosis in 
the nervous system (Orii et al., 2006). Interestingly, Xrcc2−/− embryos display massive 
apoptosis in the brain by E10.5, a stage that corresponds to the period of neural progenitor 
proliferation, whereas no apoptotic cells are detectable in Lig4−/− brains until E12.5, a time 
period when neural progenitors are differentiating into neurons (Orii et al., 2006). These 
observations also reveal that cells rely on different repair pathways depending on their status 
in the developmental program. The reliance on HR-mediated DSB repair during progenitor 
proliferation has the added advantage that its utilization likely preserves genetic information. 
In contrast, HR is unlikely to operate in neurons that have exited the cell cycle and DSB 
repair through NHEJ becomes crucial under these conditions.
Defects in NER and neurodegeneration: the cancer connection
In addition to mouse models, the numerous congenital diseases that manifest from mutations 
in DNA repair factors also underscore the importance of maintaining genomic stability in the 
nervous system (Table 2). For instance, mutations in NER components result in syndromes 
such as xeroderma pigmentosum (XP), cockayne syndrome (CS), and trichothiodystrophy 
(TTD), all of which have neurological components. While all three disorders are 
characterized by photosensitivity, patients with XP also show an elevated predisposition to 
various cancers, including skin, lung, and mucous membrane cancers, brain tumors, 
leukemia, and gastric carcinomas (Kraemer et al., 1987). In fact, such observations were the 
first to establish that the development of cancer is intimately related to the fidelity of DNA 
repair (Cleaver, 1968). However, about a quarter of XP patients also display a spectrum of 
neurological abnormalities that include microcephaly, mental retardation, deafness, 
cerebellar ataxia, and peripheral neuropathy, and these clinical presentations suggest that 
DNA repair defects are also linked to neurodegeneration (Iyama and Wilson, 2013; Mimaki 
et al., 1986). Interestingly, the fraction of XP patients that develop neurological phenotypes 
correspond to those with mutations in genes such as XPA, XPB, XPD, XPF, and XPG that 
would cripple both GG-NER and TC-NER (Iyama and Wilson, 2013). However, patients 
with mutations in XPC, and hence with defects in GG-NER alone, show no neurological 
impairments (Anttinen et al., 2008). Furthermore, patients with CS and TTD, who also have 
mutations in genes that specifically impair TC-NER, but not GG-NER, also show 
neurological symptoms but no cancer predisposition (Iyama and Wilson, 2013). Thus, it 
appears that the nervous system is especially susceptible to perturbations in TC-NER.
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Neurological consequences of unrepaired DNA strand breaks
In addition to defects in NER, neurological abnormalities have also been observed in 
individuals harboring hypomorphic mutations in certain SSBR and DSBR factors. Whereas 
these observations have been used as indicators of the importance of specific repair 
pathways in the nervous system, the non-overlapping phenotypes of mutations in genes 
within the same repair pathway have also raised new questions about whether the lack of 
DNA repair is in fact the underlying cause of neuropathology in these diseases. Despite this 
concern, however, it is impossible to ignore that mutations in diverse genes, whose products 
have well-characterized roles in the cellular DDR, have severe neuropathological effects.
Perhaps the most detailed insights into the role of DNA damage in the nervous system have 
come from studies of ataxia telangiectasia (A-T) and related disorders. A-T is caused by 
mutations in ATM, a large serine/threonine kinase that is rapidly recruited to DNA DSBs 
and coordinates virtually all aspects of the cellular DSB response, including DNA repair, 
checkpoint activation and apoptosis (Shiloh and Ziv, 2013). Although A-T is a multisystem 
disease in which patients display radiosensitivity, immunodeficiency, and a predisposition to 
malignancy, its hallmark features are neurological. These include defects in movement and 
coordination (ataxia) that develop early in childhood and confine patients to a wheelchair by 
their teenage years, marked cerebellar atrophy, lack of natural eye movements (occulomotor 
apraxia), and slurred speech (dysarthria) (Biton et al., 2008). Like with XP, the coincidence 
of neurodegeneration and cancer predisposition in individuals with mutations in a DDR 
factor suggests that the neurological defects in A-T might also arise from defects in the 
DDR.
A related disorder related to A-T known simply as A-T like disease (ATLD) is caused by 
mutations in MRE11 (Stewart et al., 1999). ATLD is an extremely rare disease, with only 
nine families and a total of 20 affected patients identified worldwide (Palmeri et al., 2013). 
Like individuals with A-T, ATLD patients also display ataxia, dysarthria, and occulomotor 
apraxia, although these features appear later in ATLD compared to A-T (Taylor et al., 2004). 
In the DSB response, the MRN complex (comprising MRE11, RAD50, and NBS1) initially 
recognizes and binds the broken DNA ends and then rapidly recruits and activates ATM. The 
similarities between A-T and ATLD only reinforce the notion that a defective DDR 
underlies the neuropathology in these diseases. However, the situation becomes complicated 
when one takes into account that mutations in another member of the MRN complex, NBS1, 
causes a disease called Nijmegen breakage syndrome (NBS), in which the primary 
neuropathological feature is microcephaly and not the progressive cerebellar degeneration 
that characterizes A-T and ATLD (Digweed and Sperling, 2004). Furthermore, in contrast to 
the situation in the nervous system, NBS shares many of the other features of A-T, including 
radiosensitivity, immunodeficiency and cancer predisposition.
Although the reason for the differences between NBS, ATLD, and A-T are not fully 
understood, an analysis of neural tissue from mouse models carrying human ATLD and NBS 
mutations is at least partially illuminating (Shull et al., 2009). When these mice were 
subjected to genotoxic stress induced by ionizing radiation, widespread apoptosis was 
observed in nervous systems of Nbs1 mutant mice, but not in the Mre11 mutants. Similar to 
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Mre11 mutants, Atm−/− mice were also resistant to DNA damage-induced apoptosis after 
ionizing radiation (Shull et al., 2009). From these studies, it appears that while both MRE11 
and NBS1 are important for ATM activity, mutations in these components have different 
effects on ATM-mediated apoptosis following DNA damage induction. Thus, while human 
NBS mutations elevate the level of DNA damage, NBS neurons also seem to possess 
sufficient ATM activity to trigger neural apoptosis, which results in microcephaly. On the 
other hand, human ATLD and A-T mutations essentially preclude apoptotic ATM activity 
and thereby allow damaged neurons to survive. These dysfunctional neurons likely perish in 
the long run, which results in neurodegeneration. Such an explanation is also supported by 
an examination of mice lacking Ligase IV, which is a core component of the NHEJ 
machinery and is essential for the repair of DNA DSBs. In humans, hypomorphic mutations 
in LIG4 result in LIG4 syndrome that is characterized by microcephaly and this feature is 
recapitulated in mice harboring a conditional deletion of Lig4 in the nervous system 
(O’Driscoll et al., 2001; Shull et al., 2009). Interestingly, the microcephaly in Ligase IV-
deficient mice can be rescued either by introducing hypomorphic Mre11 mutations or by 
deleting Atm, but not through mutations in Nbs1 (Shull et al., 2009). Taken together, the 
overlapping features of A-T and related disorders and the functional relationship between 
ATM and MRN in the DDR strongly support the model that a defective DDR contributes 
significantly to neurodegeneration.
Notwithstanding the evidence presented above, it still remains to be shown precisely how 
defects in the DDR and DNA repair cause neurodegeneration. In the case of A-T and related 
disorders, the ideal scenario would consist of a mouse model(s) that faithfully recapitulates 
the phenotypes of the corresponding disease in humans and in which at least an accrual of 
DNA damage precedes neurodegeneration. However, whereas ATM-knockout mice exhibit 
many of the characteristics of A-T, they show almost none of the neurological phenotypes 
(Katyal and McKinnon, 2008). Similarly, mice carrying hypomorphic Mre11 and Nbs1 
alleles are also devoid of neuropathology (Katyal and McKinnon, 2008). On the one hand, 
the relatively short life expectancy of mice might preclude the appearance of effects that 
manifest over two decades in humans. On the other hand, perhaps different thresholds exist 
for DNA damage-induced apoptosis between the two species. In any case, the lack of 
neuropathology in these mouse models (which recapitulate many of the non-neurological 
aspects of the respective human diseases) has been perplexing. If the issue is that mice have 
a higher threshold for DNA damage-induced apoptosis, then perhaps introducing mutations 
that more severely compromise the DDR could breach this threshold. Interestingly, a mouse 
model in which Nbs1 is conditionally deleted in the CNS seems to do exactly that (Frappart 
et al., 2005). While a null mutation in Nbs1 is embryonic lethal, its selective ablation in the 
CNS permits survival. However, the animals display both the microcephaly that is 
characteristic of human NBS patients, as well as the severe cerebellar atrophy and ataxia that 
is seen in A-T (Frappart et al., 2005). A reason for this striking phenotype could be that 
MRN is essential for the activation of not only ATM, but also another related kinase called 
ATR that senses single-stranded DNA generated by stalled or collapsed replication forks, 
and coordinates the activation of cell cycle checkpoints. Thus, multiple DDR pathways and 
the survival of both proliferating progenitors and postmitotic neurons are likely 
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compromised by the loss of Nbs1 in the CNS. These effects provide an insight into what 
might be required to model human neurodegenerative diseases in the mouse.
Every single strand matters
Several lines of evidence suggest that SSBs might be at least as (if not more) crucial in the 
nervous system. SSBs arise three times more frequently than DSBs and unrepaired SSBs 
also elicit a strong apoptotic response (Rulten and Caldecott, 2013). In addition, while SSBs 
pose a problem for both proliferating and postmitotic cells, proliferating cells have more 
options to repair SSBs than postmitotic cells. For instance, DNA replication can convert 
SSBs into DSBs and these can be accurately repaired through HR in the S/G2 phases of the 
cell cycle, whereas such mechanisms are likely absent in cells like neurons (Rulten and 
Caldecott, 2013). The discovery of two disorders called ataxia with occulomotor apraxia-1 
(AOA1) and spinocerebellar ataxia with axonal neuropathy (SCAN1) further highlights 
these points. The interesting feature is that the pathology in these disorders is almost 
exclusively restricted to the nervous system. The disease AOA1 is one of the most common 
forms of spinocerebellar ataxia and shares many phenotypic similarities with A-T, including 
age of onset, ataxia, occulomotor apraxia, and cerebellar atrophy caused by a severe loss of 
Purkinje cells (Date et al., 2001; Moreira et al., 2001). In addition, AOA1 patients also show 
cognitive impairments, hypoalbuminaemia, and hypercholesterolaemia. However, AOA1 
patients do not display the radiosensitivity or a predisposition to cancer that is seen in A-T 
patients. AOA1 is caused by mutations in the gene aprataxin (APTX), which as mentioned 
above, is involved in processing DNA ends generated as a result of abortive ligation 
reactions in the SSBR pathway (Date et al., 2001; Moreira et al., 2001). APTX encodes for a 
342 amino acid polypeptide (although a splice variant of 356 amino acids is also thought to 
exist) that consists of three distinct domains – an N-terminal forkhead-associated (FHA) 
domain, a catalytic histidine triad (HIT) domain, and a C-terminal zinc finger (ZnF) motif 
(Rass et al., 2007). Through its FHA domain, APTX interacts with phosphorylated XRCC1 
and XRCC4, whereas multiple domains of the protein bind PARP1 and p53 (Clements et al., 
2004; Gueven et al., 2004). These interactions suggest that APTX might be important for 
both the repair of both SSBs and DSBs, although its specific role in DSBR remains 
unknown. The HIT-ZnF domain is responsible for the DNA deadenylase activity of APTX 
through which it resolves 5′-AMP termini and makes them compatible for religation (Ahel 
et al., 2006; Rass et al., 2008). A majority of the mutations in AOA1 map to the HIT domain 
of APTX (Rass et al., 2007). A number of studies using AOA1 cell lines have reported 
increased sensitivity to various DNA damaging agents and neurons lacking APTX show a 
specific defect in short-patch SSBR and accumulate adenylated DNA nicks (Gueven et al., 
2004; Reynolds et al., 2009). However, like with other disease genes, Aptx−/− mice do not 
recapitulate the phenotypes of AOA1 patients, making it difficult to study the 
neurodegenerative aspects of this disease in mice (Rulten and Caldecott, 2013).
Compared to AOA1, SCAN1 is an extremely rare disease and only nine patients from a 
single Saudi Arabian family have been discovered until now (Takashima et al., 2002). Like 
AOA1, patients with SCAN1 exhibit cerebellar atrophy and show no cancer predisposition; 
however, SCAN1 has a later onset than AOA1 (average age of onset is about 15 years) and 
SCAN1 patients show no cognitive impairment or occulomotor apraxia and present milder 
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hypercholesterolaemia and hypoalbuminaemia (Takashima et al., 2002). The underlying 
mutation in SCAN1 has been mapped to a gene that encodes for tyrosyl-DNA 
phosphodiesterase 1 (TDP1) (Takashima et al., 2002). As its name suggests, TDP1 possesses 
the ability to hydrolyze a phosphotyrosyl linkage at the 3′ ends of DNA SSBs and DSBs 
(Yang et al., 1996). This sort of linkage usually arises from abortive TOP1 activity on the 
DNA (Pourquier et al., 1997). TOP1 is a topoisomerase that catalyzes the relaxation of DNA 
supercoils that form ahead of an advancing RNA or DNA polymerase. Normally, in this 
reaction, TOP1 generates an enzyme-bridged transient single strand break in which the 3′ 
end of the DNA becomes covalently attached to the active site tyrosine in TOP1. The break 
then causes the DNA to unwind and become relaxed, following which the enzyme religates 
the two ends. However, certain conditions, such as a collision between a replication fork or 
RNA polymerase with a TOP1-DNA complex or the exposure of cells to certain 
topoisomerase poisons (such as camptothecin) can result in the formation of abortive TOP1-
DNA complexes and resolving these intermediates requires TDP1.
Accordingly, SCAN1 cell lines accumulate more DNA SSBs in the presence of 
camptothecin compared to control lines and are also defective in the repair of camptothecin-
generated SSBs (El-Khamisy et al., 2005). In addition, SCAN1 cell lines also show defects 
in the repair of SSBs generated by treatment with hydrogen peroxide and ionizing radiation 
(El-Khamisy et al., 2005; Katyal et al., 2007). It is unclear whether these treatments also 
result in the accumulation of TOP1-DNA intermediates, although there is some evidence to 
suggest that TDP1 might also process other 3′ and 5′ termini that arise at SSBs and DSBs. 
Interestingly, and unlike a number of other mouse models, Tdp1−/− mice do show a 
progressive reduction in cerebellar size, which is consistent with the cerebellar atrophy in 
SCAN1 patients, although the mice do not develop ataxia (Katyal et al., 2007). Given that 
SCAN1 has a later onset, it is again likely that the short life expectancy in mice precludes 
them from developing other aspects of the disease. Nevertheless, the results from studies on 
AOA1 and SCAN1 suggest that the processing of SSBs and SSBR intermediates, especially 
abortive TOP1-DNA complexes, is extremely relevant in neurodegeneration.
DNA damage in the aging brain
No one is immune to aging, the progressive deterioration of bodily functions with time. 
Wrote Ralph Waldo Emerson, “…old age seems the only disease, all others run into this 
one”. In addition to being inevitable, the phenomenon of aging is also mysterious. For 
instance, in a classic paper titled Pleiotropy, Natural Selection and the Evolution of 
Senescence, George C. Williams (1957) observed, “It is remarkable that after a seemingly 
miraculous feat of morphogenesis a complex metazoan should be unable to perform the 
much simpler task of merely maintaining what is already formed” (Kirkwood, 2005; 
Williams, 1957). Yet, maintenance is no simple task in a cellular environment that constantly 
threatens the stability of its constituents, especially its DNA.
The consequences of genomic instability manifest in at least three important ways with age. 
The first is an accumulation of unrepaired DNA damage, which can arise from a decrease in 
DNA repair activities with age. For instance, a decline in the efficiency of BER and NHEJ 
due to a reduction in the activity of DNA glycosylases and DNA-PK, respectively, has been 
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reported in the literature. An age-dependent attenuation in DNA repair capacity has also 
been reported in the rodent and human brain. In an insightful study, microarray analysis of 
post-mortem human brain samples as a function of age revealed that genes encoding for 
critical neuronal functions, including synaptic plasticity, learning, and memory are 
downregulated after age 40 and concomitantly, the expression of stress response genes is 
upregulated (Lu et al., 2004). Importantly, this dramatic change in gene expression profiles 
is accompanied by an accumulation of oxidative lesions in the promoter regions of the 
downregulated genes (Lu et al., 2004), suggesting that an accrual of oxidative lesions could 
underlie the decline in cognitive abilities with age.
Another way in which DNA damage participates in aging is through the erroneous repair of 
DNA lesions that results in mutations (Vijg and Suh, 2013). In contrast to unrepaired 
lesions, which are reversible, mutations are irreversible and can therefore be highly 
problematic. For instance, the use of a transgenic mouse model that harbors a 
chromosomally integrated reporter that can be sequenced to assay for mutations as a 
function of age revealed that mutations in the liver almost quadrupled with age (Dolle et al., 
1997). Interestingly, no such differences were found in the brain under these conditions. 
However, only a few chromosomal loci were sampled in this study and it is therefore 
formally possible that mutations accumulate at certain “hotspots” in the aging human brain. 
Mutations could also contribute to age-related neurodegeneration in a more indirect way. In 
an interesting study, single cell genomic analysis of post-mortem neurons from the human 
frontal cortex revealed that between 13 and 41% of neurons have copy number variations 
(CNVs) of at least one megabase (McConnell et al., 2013). The specific consequences of 
somatic mosaicism in the human brain is presently unknown; however, it would be 
interesting to determine whether CNVs in the brain increase as a function of age or in 
certain age-related neurodegenerative disorders. A more direct effect of mutations on 
neurodegeneration is clearly evident when these mutations compromise the activities of 
DNA repair/DDR factors (see below). In addition to direct alterations to the composition and 
structure of DNA, the formation of DNA damage also elicits substantial changes to 
chromatin organization. While a number of these changes serve necessary functions in DDR 
signaling, there is also evidence to suggest that chromatin conformation might not be 
restored to its pre-damaged state following DNA repair (Oberdoerffer and Sinclair, 2007; 
Tamburini and Tyler, 2005). Thus, DNA damage could progressively alter chromatin 
conformation, and thereby, gene expression patterns, with age. In fact, a number of studies 
have reported age-associated changes in the epigenome (Krishnan et al., 2011; Peleg et al., 
2010; Vijg and Suh, 2013), although precisely what fraction of these changes is a result of 
DNA damage remains unclear.
The studies described thus far highlight the local consequences of DNA damage, through 
lesions, mutations and epigenomic changes at the sites of damage. However, other studies, 
especially those conducted by Sinclair and colleagues, suggest that DNA damage can also 
trigger global changes in chromatin architecture (Oberdoerffer et al., 2008; Oberdoerffer and 
Sinclair, 2007). They observed that the exposure of cells to DNA damaging agents, 
including hydrogen peroxide, and the generation of site-specific DNA DSBs leads to a 
redistribution of SIRT1 from various loci, including repetitive DNA elements, to the sites of 
DNA damage (Oberdoerffer et al., 2008). The localization of SIRT1 is essential for DNA 
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repair and therefore beneficial in the short-term; however, chronic genotoxic stress during 
and a persistent redistribution of SIRT1 causes large-scale transcriptional deregulation of 
genes normally targeted by SIRT1. Interestingly, the gene expression changes that result 
from SIRT1 redistribution parallel those in the aging mouse brain (Oberdoerffer et al., 
2008). These results raise the possibility that pharmacological SIRT1 activation can impact 
aging in at least two ways: by stimulating the repair of damaged DNA and by promoting the 
transcriptional regulation of repetitive elements and other loci normally targeted by SIRT1. 
In addition to these mechanisms, telomere dysfunction is thought to be a major underlying 
factor in aging (Sahin and DePinho, 2012), although its specific roles in the aging human 
brain requires further characterization.
DNA damage in age-associated neurodegenerative disorders
In addition to normal aging, defective DNA repair has also been linked with age-associated 
neurodegenerative disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), 
and amyotrophic lateral sclerosis (ALS). For instance, elevated levels of DNA strand breaks, 
a reduction in the levels of DSB repair proteins such as DNA-PKcs and MRN complex 
proteins, and decreased BER activity have been described in AD patients compared to age-
matched controls (Adamec et al., 1999; Jacobsen et al., 2004; Mullaart et al., 1990; 
Shackelford, 2006). Similarly, elevated levels of oxidative lesions and SSBs have been 
reported in the neurons of ALS patients and damage to mitochondrial DNA has been 
documented in PD (Bender et al., 2006; Kraytsberg et al., 2006; Martin, 2001). While these 
studies certainly raise the possibility that defects in the DDR underlie brain aging and the 
development of age-related neurodegenerative disorders, it should be noted that these studies 
are largely correlative in nature and that our understanding of the specific contribution of 
DNA damage to the etiology of these disorders is still only rudimentary. To say that DNA 
damage has a causal effect in the neuropathology of AD, PD, or ALS requires specifying 
what lesions, if any, have a higher propensity to accumulate in the diseased neurons, 
identifying the molecular mechanisms that preclude the repair of these lesions, developing 
animal models in which lesion accumulation mimics at least some aspects of the 
pathophysiology of human neurodegenerative disorders and ideally, that promoting DNA 
repair can alleviate these effects. While an understanding of each of these questions is 
currently limited, recent studies are fast changing the status quo.
A major issue concerns understanding which lesions are central to the progression of a given 
neurodegenerative disease. Generally, oxidative DNA lesions have received much attention 
because the brain has a relatively high metabolic rate, generates more ROS, and is thought to 
have a decreased ratio of antioxidant to pro-oxidant enzymes, all of which translates into a 
stateof elevated oxidative stress (Canugovi et al., 2013). As mentioned above, the BER 
pathway is primarily involved in the repair of oxidative lesions and consists of enzymes 
called DNA glycosylases that specialize in lesion recognition and initial processing. It has 
been reported that expression and activity of various BER factors changes both with age and 
in disorders such as AD. For instance, the expression of both UDG1 and βOGG1 
glycosylases, as well as polβ, were found reduced in AD brains compared to age-matched 
controls (Canugovi et al., 2013). However, knockout mouse models of various DNA 
glycosylases show none of the drastic phenotypes of human neurodegenerative disorders. In 
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addition, transgenic mouse models of AD do not exhibit BER deficits. On the one hand, the 
lack of an overt phenotype in mice lacking DNA glycosylases is reminiscent of mouse 
models of the various neurodevelopmental disorders described above. On the other hand, 
whereas mutations in DDR factors actually underlie the neurodevelopmental disorders, 
mutations in BER factors have so far not been observed in neurodegenerative disorders. 
Thus, the specific contribution to age-related neurodegeneration of at least the subset of 
oxidative lesions that are repaired through BER remains unclear. In contrast to mouse 
models of BER mutants, conditional mouse models in which Ercc1 was specifically deleted 
in excitatory neurons of the forebrain showed reduced synaptic plasticity in the 
hippocampus, as well as memory impairments that are characteristic features of age-related 
neurodegenerative disorders (Borgesius et al., 2011). Because Ercc1 is a component of the 
NER pathway, these results raise the possibility that NER deficits could underlie age-related 
neurodegeneration. However, Ercc1 also participates in the repair of DNA DSBs and 
crosslinks, and like with BER factors, NER mutations have so far not been identified in age-
related neurodegenerative disorders.
In addition to oxidative lesions, the notion that DNA strand breaks might contribute 
significantly to the pathology of age-related neurodegenerative diseases has recently gained 
traction. First, DNA strand breaks are elevated in disorders such as AD and ALS (Adamec et 
al., 1999; Martin, 2001; Mullaart et al., 1990). In addition, elevated levels of DNA DSBs 
have now been reportedin several mouse models of neurodegeneration (Dobbin et al., 2013; 
Kim et al., 2008; Suberbielle et al., 2013). Among these, studies conducted on the p25/Cdk5 
mouse model have been particularly illuminating. Cyclin-dependent kinase 5 (Cdk5) is a 
brain-specific serine/threonine kinase that requires its cyclin-like partner, p35, for catalytic 
activity (Lew et al., 1994; Tsai et al., 1994). Studies conducted over a dozen years have 
informed that in the AD brain as well as under other neurotoxic conditions, p35 undergoes 
proteolytic cleavage to generate p25 and that the association of p25 with Cdk5 changes the 
substrate specificity and subcellular localization of Cdk5 (Su and Tsai, 2011). These 
observations prompted the generation of the inducible p25/CDK5 mouse model (CK-p25 
mice) (Cruz et al., 2003). Upon induction, CK-p25 mice express p25 in a forebrain-specific 
manner and systematically recapitulate various AD-like pathologies including the 
accumulation of amyloid-β peptides, neurofibrillary tau tangles, astrogliosis, reduced 
synaptic density and neuronal loss in the forebrain (Cruz et al., 2006; Cruz et al., 2003). 
Remarkably, an analysis of pre-symptomatic CK-p25 mice revealed that an accrual of DNA 
DSBs in the forebrain precedes the appearance of all other pathological hallmarks and 
suggests that DSBs could be the initiating lesion of neurotoxicity in these mice (Kim et al., 
2008). The unexpected discovery of DSBs in a mouse model of neurodegeneration triggered 
further investigations into the mechanisms underlying their accumulation in CK-p25 mice. 
These studies attributed the elevated DSBs to an inhibition of the class I histone deacetylase, 
HDAC1, in CK-p25 mice and found that overexpression of HDAC1 suppressed both the 
increased susceptibility to DSBs and the neuronal loss caused by p25 overexpression (Kim 
et al., 2008). However, a separate study noted that overexpression of the NAD+-dependent 
deacetylase, SIRT1, can also prevent neuronal loss in CK-p25 mice (Kim et al., 2007). 
Meanwhile, several groups working in dividing cells reported that SIRT1 is essential for the 
recruitment of NBS1 and RAD51 to the sites of DNA DSBs and that HDAC1 plays an 
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important role in DSB repair through the NHEJ pathway (Oberdoerffer et al., 2008; Yuan et 
al., 2007). These observations suggested that the neuroprotective functions of SIRT1 and 
HDAC1 in CK-p25 mice might arise from their roles in the neuronal DSB response. A direct 
exploration of the functions of SIRT1 and HDAC1 in the DSB response of postmitotic 
neurons has provided further insights into this question (Dobbin et al., 2013). Neurons 
lacking either SIRT1 or HDAC1 are more susceptible to DSB-inducing agents and are 
deficient in DSB repair. Both SIRT1 and HDAC1 also localize rapidly to the sites of DNA 
DSBs and SIRT1 specifically exhibits a co-dependent relationship with ATM for its 
recruitment to DSBs and also stimulates the autophosphorylation and activity of ATM 
(Dobbin et al., 2013). Interestingly however, SIRT1 also shares an enzyme-substrate 
relationship with HDAC1 in which SIRT1 deacetylates and stimulates the catalytic activity 
of HDAC1 and helps recruit HDAC1 to the sites of DNA damage. The effects of SIRT1 on 
HDAC1 activity can also be achieved by treatment with pharmacological activators of SIRT1 
both in vitro and in vivo (Dobbin et al., 2013). Finally, pharmacological activation of SIRT1 
is able to stimulate HDAC1 deacetylation, reduce DSB formation and improve neuronal 
survival in CK-p25 mice. Taken together, the studies involving CK-p25 mice not only 
implicate DSBs as a lesion that could underlie neurodegeneration, but also provide new 
clues into activities that could guard against genomic instability and preserve neuronal 
viability.
Although extremely cytotoxic, DSB formation is also incredibly rare even in proliferating 
cells, where DNA replication is an important source of these lesions. The notion of DSBs 
being important for age-related neurodegeneration therefore requires identifying the 
processes that lead to their formation in the first place. Interestingly, a recent report indicates 
that physiological neural activity, including performing new learning tasks, itself can 
introduce DSBs within neurons (Suberbielle et al., 2013). Moreover, using an AD mouse 
model, the authors show that amyloid β generation exacerbates the accumulation of these 
DSBs (Suberbielle et al., 2013). At present, it is still unclear whether these DSBs serve a 
physiological purpose or whether they are merely a consequence of the changes that occur 
during neuronal activation, and further studies in this line should illuminate the precise risk 
posed by DSB formation induced during neural activity. Nonetheless, these results provide 
new evidence to suggest that DSBs are in fact produced in neurons under physiological 
conditions and that their repair could govern neuronal survival in neurodegenerative 
diseases.
A potential strategy to determine the role of DDR defects in age-related neurodegeneration 
consists of understanding whether mutations that cause the familial forms of these disorders 
also perturb the DDR. While such connections remain largely obscure, recent studies 
involving the RNA/DNA binding protein, FUS, could represent a breakthrough in this 
direction. In 2009, two studies identified more than a dozen mutations in FUS that are linked 
with familial ALS (fALS) and found that these mutations cause FUS to be deposited in the 
cytoplasm (Kwiatkowski et al., 2009; Vance et al., 2009). Based on its similarity to another 
RNA binding protein called TDP-43 that was also implicated in familial ALS, a majority of 
studies on FUS have since centered on its role in RNA processing (Lagier-Tourenne and 
Cleveland, 2009). Interestingly however, FUS (which stands for Fused in Sarcoma) was also 
shown to be important for genomic stability more than a decade ago. For instance, Fus−/− 
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mice suffer from high levels of genomic instability, defective B-lymphocyte development, 
male sterility, and undergo perinatal death, and FUS was shown to participate in D-loop 
formation, which is an intermediate step in DNA repair through HR (Baechtold et al., 1999; 
Hicks et al., 2000; Kuroda et al., 2000). Recently, several independent studies have 
demonstrated the rapid recruitment of FUS to laser induced DNA damage sites, which is 
crucial for efficient DSB repair (Mastrocola et al., 2013; Rulten et al., 2013; Wang et al., 
2013). FUS recruitment to DSBs depends on the enzymatic activity of PARP-1, but not on 
DNA-PK or ATM, and in FUS knockdown neurons, the response to treatment with DSB 
inducing agents is dampened. Moreover, stable tethering FUS to chromosomes in the 
absence of a DSB is sufficient to elicit the DDR (Wang et al., 2013). Thus, FUS appears to 
be an early component that participates in the initial steps of DDR signaling. Furthermore, 
FUS directly interacts with HDAC1, and the interacting domains map to the G-rich and C-
terminal domains within FUS, where the majority of the fALS mutations are also 
concentrated. fALS FUS mutants display an impaired interaction with HDAC1 and lead to 
deficient DNA repair (Wang et al., 2013). Importantly, when motor cortex samples from 
ALS patients harboring c-terminal FUS mutations were analyzed, it was found that the 
amount of DNA damage is significantly enriched compared to normal brain tissues (Wang et 
al., 2013). Together, these studies suggest that the dysfunction of FUS in DSB signaling and 
repair could contribute to the disease progression of FUS linked fALS.
In conclusion, it is becoming increasingly clear that the DNA damage response is important 
during both neural development and in the mature nervous system. Mutations in core DNA 
repair factors are either incompatible with life, or even when tolerated, manifest in severe 
neurodevelopmental disorders. On the other hand, determining the specific contribution of 
DNA damage to brain aging and neurodegeneration remains a complex problem. The 
vulnerability of postmitotic neurons to certain types of DNA damage (such as oxidative 
lesions or certain DNA strand break lesions) coupled with a gradual decline in the activities 
of corresponding repair mechanisms could lead to their accumulation with age and 
contribute to brain aging and neurodegeneration. In addition, mutations in certain DDR 
factors (such as FUS) could exacerbate these effects and predispose individuals to 
neurodegeneration. In the future, identification of the specific lesions that accumulate in 
human age-related neurodegenerative diseases and the generation of new conditional mouse 
models are likely to provide key insights into which activities should be targeted in 
therapeutic strategies to combat these disorders.
List of Abbreviations
DDR DNA damage response
NHEJ nonhomologous end joining
HR homologous recombination
ROS reactive oxygen species
BER base excision repair
NER nucleotide excision repair
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GG-NER global genome NER
TC-NER transcription coupled NER
SSBs single strand breaks
DSBs double strand breaks
PAR poly-(ADP-ribose)
HAT histone acetyltransferase
HDAC histone deacetylase
XP xeroderma pigmentosum
CS Cockayne syndrome
TTD trichothiodystrophy
A-T ataxia telangiectasia
ATLD A-T like disease
NBS Nijmegen breakage syndrome
AOA1 ataxia with occulomotor apraxia-1
SCAN1 spinocerebellar ataxia with axonal neuropathy
CNV copy number variation
AD Alzheimer’s Disease
PD Parkinson’s Disease
ALS Amyotrophic lateral sclerosis
fALS familial Amyotrophic lateral sclerosis
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Figure 1. The single strand break repair pathway
It is not clear whether BER and TOP1-mediated SSBs actually require a sensing step; 
however, direct breaks are detected by polyADP ribose polymerase 1 (PARP1). Various 
activities collaborate to generate 3′ OH and 5′P ends that are compatible for ligation. For 
instance, 3′ phosphoglycolate, and 3′ phosphate and 5′ OH intermediates generated from 
ROS-mediated sugar disintegration, and products of abortive TOP1 reactions are variously 
processed by APE1 PNKP, and TDP1, respectively. Occasionally, failure of ligation can 
result in the formation of a 5′AMP-associated SSB, which is processed by APTX. Like in 
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BER, any gap-filling synthesis is mediated by polβ and nicks are sealed by either XRCC1/
LIG3 or FEN1/LIG1.
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Figure 2. The NHEJ pathway of DNA double strand break repair
KU70/KU80 heterodimer binds to the broken DNA ends and recruits the catalytic subunit of 
the DNA-dependent protein kinase, DNA-PKcs. Activation of DNA-PKcs allows end-
processing proteins such as the ARTEMIS, to access the broken DNA ends and DNA 
polymerase (i.e. pol μ and pol λ) to fill in the gap. The XRCC4/LIG4 complex is then 
recruited to promote religation.
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Figure 3. Chromatin modifications in the DDR
The formation of DNA DSBs triggers various chromatin modifications, including poly-
ADP-ribosylation mediated by PARP1; histone acetylation/deacetylation mediated by HAT 
such as p300, MOF and TIP60, and HDAC, such as HDAC1, SIRT1 and SIRT6; and ATM-
dependent H2AX phosphorylation and RNF8/RNF168 mediated H2A ubiquitination. ATP-
dependent chromatin remodelers can slide, exchange or evict histone dimers or octamers. 
The consequences of these modifications are depicted, with details provided in the text. 
H2AX containing nucleosomes are shown in orange.
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Figure 4. The Lock, Loosen, Load Model of chromatin dynamics
DNA damage triggers chromatin compaction in the vicinity of damaged sites that allows the 
broken DNA ends to be stabilized or “locked” and to inhibit transcription in regions adjacent 
to damaged DNA. This transient state is quickly followed by chromatin relaxation 
(“Loosen”) that allows a plethora of DNA repair proteins to be recruited (Loaded) to the 
sites of damage.
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Figure 5. The consequences of DNA damage in aging and neurodegeneration
(Left) Erroneous repair of DNA damage can lead to the formation of mutations, which are 
irreversible and perturb tissue homeostasis in the nervous system by essentially promoting 
the formation of mosaics. Occasionally, mutations could occur in DNA repair factors (such 
as FUS, see text) and this can manifest in profound neurodegeneration (red arrow). (Middle) 
In contrast, although reversible, the accumulation of unrepaired lesions due to decreased 
DNA repair activities can block the transcription of genes encoding for critical neural 
functions and downregulate their activity, leading to cognitive decline. (Right) DNA damage 
also affects the epigenetic landscape. DNA damage-induced epigenetic changes can accrue 
over time as “epimutations” and affect gene expression. In addition, the redistribution of 
epigenetic modulators, such as SIRT1, can trigger global changes to the chromatin 
architecture, leading to large-scale transcriptional deregulation of their normally repressed 
targets, such as major satellite repetitive DNA.
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Table 2
Human neurological diseases linked to mutations in DNA repair genes
Repair Pathway Affected Human Syndromes & Clinical Features Mutated gene Mouse Models
NER Cockayne Syndrome (CS): developmental 
failure, premature aging, progressive 
neurodegeneration, deafness, 
myelinopathy, UV-sensitivity
ERCC8/CSA Csa−/− mice: impaired TC-NER, 
photoreceptor loss, UV sensitivity, 
lacking gross abnormalities (van der 
Horst et al., 2002)
ERCC6/CSB Csb mutants mimicing human CS1AN 
allele: mild CS–like symptoms 
including minor neurologic 
abnormalities; impaired TC-NER; UV 
sensitivity (van der Horst et al., 1997)
XPB, XPD Xpb frameshifted homozygous or Xpd 
null mutants: early embryonic lethality 
(may caused by disruption in basal 
transcription) (de Boer et al., 1998b);
XpbXPCS mutants mimicking human 
XP11BE allele: UV hypersensitivity, no 
overt developmental or aging 
phenotypes.
Xpa&XpbXPCS double mutants: CS like 
symptoms including accelerated aging, 
neurological defects, big phenotypic 
variation. (Andressoo et al., 2009)
XPG Xpg−/− mice: postnatal growth failure, 
short life span (Harada et al., 1999)
Xeroderma Pigmentosum (XP): 
predisposed to UV-induced skin cancer, a 
quarter of XP patients develop 
neurological symptoms including 
microcephaly, mental retardation, 
deafness, cerebellar ataxia, and peripheral 
neuropathy
XPA–XPG Xpa−/− or Xpc−/− mice: UV sensitivity, 
normal development, no overt 
neurological abnormalities;
Xpa−/−; Csb−/− or Xpc−/−; Csb−/− double 
mutants: CS and XP like symptoms 
including growth retardation, ataxia, 
motor dysfunction, reduced cerebellar 
neurogenesis and neurodegeneration. 
(Laposa et al., 2007; Murai et al., 2001)
Xpf−/− mice: UV hypersensitivity, 
developmental defects, short life span 
(Tian et al., 2004)
Trichothiodystrophy (TTD): brittle hair, 
growth defects, photosensitivity.80% of 
TTD patients show neurological 
abnormalities including microcephaly, 
mental retardation, deafness and ataxia
XPD Xpd722W mutants: TTD like symptoms 
including brittle hair, developmental 
abnormalities, reduced life span and UV 
sensitivity (de Boer et al., 1998a)
TTDA Ttda−/− mice are embryonic lethal, 
completely NER deficient, 
hypersensitive to oxidative DNA 
damage (Theil et al., 2013).
SSBR Ataxia with Occulomotor Apraxia-1 
(AOA1): ataxia, occulomotor apraxia, 
cerebellar atrophy and cognitive 
impairments
APTX Aptx−/−; Tdp1−/− mice: significantly 
slower SSBR rate with intact DSBR(El-
Khamisy et al., 2009)
Spinocerebellar Ataxia with Axonal 
Neuropathy (SCAN1): cerebellar atrophy
TDP1 TdpF−/− mice: progressive cerebellar 
atrophy, defects in SSB repair(Katyal et 
al., 2007a)
DSBR Ataxia Telangiectasia (A-T): ataxia, wide 
spread cerebellar atrophy, occulomotor 
apraxia, dysarthria, immunodeficiency 
and cancer predisposition
ATM Atm−/− mice: growth retardation, 
immunodeficiency, meiotic failure, 
cancer predisposition and no obvious 
cerebellar atrophy. One mutant line 
shows abnormal motor function (Barlow 
et al., 1996), the other reveals microglia 
activation and mild cerebellar 
degeneration (Kuljis et al., 1997; Xu et 
al., 1996)
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Repair Pathway Affected Human Syndromes & Clinical Features Mutated gene Mouse Models
A-T Like Disease (ATLD): ataxia, 
dysarthria, and occulomotor apraxia
MRE11 Mre11−/− or Mre11H129N/H129N 
(disrupting nuclease activity) mice: early 
embryonic lethality, genome instability, 
although Mre11H129N/H129N can activate 
ATM normally (Buis et al., 2008).
ATR-Seckel Syndrome: microcephaly, 
dwarfism
ATR Atr−/− mice: early embryonic lethality 
(de Klein et al., 2000)
AtrS/S (mimicking seckel mutation, a 
severe hypomorphism): microcephaly, 
dwarfism, accumulated replicative 
stress, progressive aging (Murga et al., 
2009)
Nijmegen Breakage Syndrome (NBS): 
microcephaly, immunodeficiency and 
cancer predisposition
NBS1 NbsF−/− mice: early embryonic lethality 
(Zhu et al., 2001)
LIG4 Syndrome: microcephaly LIG4 Lig4−/− mice: late embryonic lethality; 
p53 dependent apoptosis of postmitotic 
neuron (Frank et al., 1998; Frank et al., 
2000)
XLF Syndrome: microcephaly, growth 
retardation, immunodeficiency
XLF/NHEJ1/Cernunnos XLF−/− mice: no obvious neuronal cell 
death, relatively normal lymphocyte 
development, increased ionizing 
radiation sensitivity (Li et al., 2008).
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